Circuit Training Program for Persons With Spinal Cord Injury

February 7, 2020 updated by: Dalton Wolfe, Lawson Health Research Institute

Circuit Training Program Tom Improve Endocrine-Metabolic Function in Persons With Spinal Cord Injury

This initiative represents development and pilot testing of a circuit training exercise program for persons with spinal cord injury (SCI) to be implemented within a rehabilitation centre. The program will integrate members of the community who are > 18 months post-injury with those currently participating in SCI rehabilitation as inpatient.

Study Overview

Status

Unknown

Detailed Description

This initiative represents development and pilot testing of a 16 week circuit training exercise program for persons with spinal cord injury (SCI) to be implemented within a rehabilitation centre (Parkwood Institute, London, ON). The primary purpose of this trial is one of feasibility - i.e., testing out several aspects of the trial for the purposes of determining what features of the exercise intervention and the various outcome measurements might be a part of subsequent trials. In addition, a subset of this data will serve as preliminary comparison information for Dr. Dany Gagnon's study at the University of Montreal. In this way, this is not a true multi-centre trial in that we are not conducting an identical protocol to a study he is conducting. Rather, we are using some of the same outcome measures and an exercise intervention that has some similar parameters to one that he is implementing in Montreal - with a view to providing a preliminary comparison of outcomes of a subset of participants in our study so as to inform the development of future studies. For this reason, the group of community-dwelling persons with SCI will have more cardio-metabolic outcome measurements taken, as they represent the primary group of interest to Dr. Gagnon.

Overall, the program will integrate members of the community who are > 18 months post-injury (n=8) with those currently participating in SCI rehabilitation as inpatients (n=8). Outcomes will be collected to test the effects of the program on an array of cardio-metabolic measures in those participants with chronic SCI, as well as the feasibility of the program for all participants (N=16). Note: although a participant can decline to continue participation at any time, it is likely that many inpatient participants will choose to not continue participation if this proves logistically difficult (if they move back to their home community away from London).

Study Type

Interventional

Enrollment (Anticipated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Community:

  • Chronic traumatic or non-traumatic SCI between level C6 and T10 >18 months post injury
  • manual wheelchair as the primary mode of mobility
  • no existing conditions that would make it unsafe to participate in an exercise program (e.g., fractures).
  • Ability to understand and communicate in English.
  • 18 years or older.

Inpatients:

  • Chronic traumatic or non-traumatic SCI between level C6 and T10
  • manual wheelchair as primary mode of mobility
  • no existing conditions that would make it unsafe to participate in an exercise program (e.g., fractures).
  • Ability to understand and communicate in English.
  • 18 years or older.

Exclusion Criteria:

  • Power wheelchair users (Non manual wheelchairs)
  • Have an existing condition that would make it unsafe to participate in an exercise program (e.g., fracture)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Upper Body Exercise
Seated upper body circuit training program for 16-weeks. Frequency - 1 to 3 one-hour sessions per week.
16 week seated upper body exercise for persons with Spinal Cord Injuries. Participants will attend 2-3 exercise sessions a week, sessions have a mix of SCI community members and inpatients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility survey
Time Frame: After Study Completion (16 weeks)
Feasibility question options range from -3 to +3 on a likert scale, higher scores indicated a greater level of feasibility.
After Study Completion (16 weeks)
Injury Characteristics Survey
Time Frame: Baseline
Date of injury (DD/MM/YYYY)
Baseline
Injury Characteristics Survey
Time Frame: Baseline
Diagnosis - Traumatic SCI or Non-Traumatic SCI
Baseline
Injury Characteristics Survey
Time Frame: Baseline
Classification of SCI using the AIS (ASIA Impairment Scale) - A, B, C, D or E
Baseline
Injury Characteristics Survey
Time Frame: Baseline
Neurological Level or Injury (NLI)
Baseline
Change in Spinal Cord Injury Independence Measure - Mobility
Time Frame: Baseline and 16 weeks
Assessment of degree to which participant can independently preform mobility tasks, such as transfers, and the ue of mobility aids.
Baseline and 16 weeks
Change in Upper and Lower Extremity Strength by a manual muscle test (MMT)
Time Frame: Baseline and 16 weeks
Assessment of joint (Shoulder, elbow, wrist, hip, knee and ankle) muscle strength using a Manual muscle test.
Baseline and 16 weeks
Change in Upper and Lower Extremity Range of Motion
Time Frame: Baseline and 16 weeks
Assessment of joint range of motion in the upper and lower extremities (Shoulder, elbow, wrist, hip, knee and ankle)
Baseline and 16 weeks
Change in Spasticity in upper and lower extremities using the Modified Ashworth Scale
Time Frame: Baseline and 16 weeks
Assessment of muscle tone through range of motion, on a scale of 0-4 (0= no increase in muscle tone; 4 = rigidity in flexion or extension)
Baseline and 16 weeks
Change in Maximal Safe Wheel chair speed measured using the Propulsion Speed Test
Time Frame: Baseline and 16 weeks
20 meter straight line wheel chair speed test. 3 trails were be preformed at a comfortable speed and 3 trials will be preformed at a maximal but safe speed.
Baseline and 16 weeks
Change in Ability to safety navigate wheel chair using the Slalmon Speed test
Time Frame: Baseline and 16 weeks
Objective is to weave between a set of cones without touching them as fast as safely possible. 3 attempts will be given.
Baseline and 16 weeks
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Age in years
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Gender (Women, Man or Other)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Marital Status
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Ethnicity
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Highest Education Level completed
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Currently Employment situation
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Family income ($ in last year)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
List of Medical/health problems
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Smoking levels (yes/no and how many years)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Cannabis Use (yes/no, frequency, types of products)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Vaping (Yes/no, frequency)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Alcohol consumption (frequency and beverages consumed when drinking)
Baseline
Demographics and Lifestyle Questionnaires
Time Frame: Baseline
Physical Activity levels (minutes/week)
Baseline
Change in Medications
Time Frame: Baseline and 16 weeks
List of medication and supplements currently being taken.
Baseline and 16 weeks
Change in Experienced Pain
Time Frame: Baseline and 16 weeks
The international Spinal Cord Injury Pain Data Set will be used to evaluate the presence and severity of pain. Description of 3 main pain concerns and there intensity. Intensity ranges from 0 = no pain to 10 = worst possible pain.
Baseline and 16 weeks
Change in Wheel Chair skills ability using the Wheel Chair skills Test Questionnaire
Time Frame: Baseline and 16 weeks
Questionnaire assesses the ability and confidence in preforming numerous wheel chair skills (ex: turning the wheelchair around a small space) Questions answers include 'No' 'partially' 'yes' 'very well'.
Baseline and 16 weeks
Change in Well Being measured by the General Wellbeing Index
Time Frame: Baseline and 16 weeks
Assessment of emotional wellbeing, on a scale of 0-5.
Baseline and 16 weeks
Change in Quality of life and health measured by the WHOQOL-BREF
Time Frame: Baseline and 16 weeks
Self reported questionnaire assessing quality of life (physical, social, environment and psychological health) on a scale of 1 - 4 (1=poor/not al all; 5= very good/extreme amount)
Baseline and 16 weeks
Change in aerobic capacity (VO2max) measured by 6-min wheelchair propulsion test
Time Frame: Baseline and 16 weeks
Objective is to get the largest total distance. Pylons are placed 25meters apart, participants starts in the middle go around the first cone to the let return to the middle and make a full stop, then continue to the right of second cone, go around it and back to the middle, making a figure 8. Continue that pattern for 6 minutes.
Baseline and 16 weeks
Blood Test
Time Frame: Baseline and 16 weeks
Measurement of metabolic profile (ex: glucose, insulin, triglyceride)
Baseline and 16 weeks
Blood Test
Time Frame: Baseline and 16 weeks
Measurement of bone markers (ex: osteocalcin)
Baseline and 16 weeks
Change in Body composition measured by DEXA (Dual energy x-ray absorptiometry)
Time Frame: Baseline and 16 weeks
Measurement of bone mineral density of the full body (reported using a T score)
Baseline and 16 weeks
Change in Body composition measured by DEXA (Dual energy x-ray absorptiometry)
Time Frame: Baseline and 16 weeks
Measurement of bone mineral density of the femoral head (reported using a T score)
Baseline and 16 weeks
Change in Body composition measured by DEXA (Dual energy x-ray absorptiometry)
Time Frame: Baseline and 16 weeks
Measurement of bone mineral density of the lumbar spine (reported using a T score)
Baseline and 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

February 1, 2020

Primary Completion (ANTICIPATED)

May 1, 2020

Study Completion (ANTICIPATED)

July 1, 2020

Study Registration Dates

First Submitted

December 5, 2019

First Submitted That Met QC Criteria

February 7, 2020

First Posted (ACTUAL)

February 10, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Upper Body Circuit Training Program

Subscribe